Episode Details

In his weekly clinical update Dr. Griffin reviews the public health response to poliovirus in New York, impact of mandatory influenza vaccination, monkeypox in a young infant, health care worker exposure to monkeypox virus, monkeypox testing delays, transmission potential of monkeypox virus, TPOXX trial for monkeypox, detection of SARS-CoV-2 subgenomic mRNA, mucosal IgA against SARS-CoV-2, BNT262b2 against Omicron, awareness and use of SARS-CoV-2 antivirals, comparable outcomes for Bebtelovimab and Nirmatrelvir, and COVID-19 and Alzheimer's disease.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

• Support MicrobeTV with a Spike t-shirt at Vaccinated.US
• Research assistant position with Amy Rosenfeld (pdf)
• Public health response to polio in New York (MMWR)
• Impact of mandatory influenza vaccination (Cambridge Core)
• Monkeypox in young infant (MMWR)
• Health care worker exposure to monkeypox virus (MMWR)
• Monkeypox testing delays (Cambridge Core)
• Monkeypox in smallpox vaccinated patient (Emerg Inf Dis)
• Transmission potential of monkeypox virus (Int J Epidemiol)
• TPOXX trial for monkeypox (ACTG)
• SARS-CoV-2 subgenomic mRNA detection (J Inf Dis)
• Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis)
• Anti-spike mucosal IgA (NEJM)
• BNT262bs against Omicron sublineages (NEJM)

• Listen Now